In the present study, we demonstrated that mRNA expression levels of hBD-1, LL-37, and trappin-2 were significantly higher in nasopharyngeal swab specimens from COVID-19 patients compared to non-infected controls. This evidence concerns the gene CAMP and COVID-19.